How pancreatic cancer is detected

Pancreatic cancer is usually found through a combination of imaging tests and blood work, often after a person reports symptoms like abdominal pain, yellowing skin, or unexplained weight loss. Because the pancreas sits deep inside the body, doctors cannot feel it during a physical exam, so they rely on scans to see it. The most common first step is a CT scan or ultrasound, which creates pictures of the pancreas and surrounding organs. If those images show something unusual, doctors order more specific tests to confirm whether it is cancer and, if so, how far it has spread.

Finding pancreatic cancer early is difficult because the pancreas is hidden behind other organs and early symptoms are often vague. Many cases are not caught until the cancer has already grown or spread. However, people with a family history of pancreatic cancer or certain genetic conditions may be screened before symptoms appear, which can sometimes lead to earlier detection.

Key Takeaways

  • CT scans and ultrasounds are the first imaging tests used to look at the pancreas when cancer is suspected.
  • A biopsy—taking a small tissue sample from the pancreas—is usually needed to confirm pancreatic cancer and determine its type.
  • Blood tests that measure tumor markers like CA 19-9 can support a cancer diagnosis but are not definitive on their own.
  • Once cancer is confirmed, additional scans (MRI, PET scan) help doctors determine whether it has spread to other parts of the body.
  • People with a strong family history or genetic mutations may be offered screening even without symptoms.

Imaging tests that show the pancreas

When a doctor suspects pancreatic cancer, imaging is almost always the first step. A CT scan (computed tomography) takes multiple X-ray images from different angles and combines them into detailed cross-section pictures of the pancreas, liver, and surrounding organs. This scan can show the size and location of a tumor and whether it appears to be growing into nearby structures. CT scans are fast—usually taking 10 to 30 minutes—and are available at most hospitals and imaging centers.

An ultrasound uses sound waves to create images and is sometimes used as an initial screening tool, especially if a patient is already in the hospital or clinic. Ultrasound does not use radiation and is less expensive than CT, but it is less detailed and depends on the skill of the person performing it. If an ultrasound raises concern, a CT scan almost always follows.

An endoscopic ultrasound (EUS) combines ultrasound with a thin, flexible tube called an endoscope that the doctor guides down the throat, through the stomach, and close to the pancreas. This allows the ultrasound probe to get much closer to the pancreas than a standard ultrasound can, producing clearer images. EUS is often used when a CT scan has found something suspicious and a biopsy is needed.

Biopsy: confirming cancer with tissue

Imaging alone cannot confirm pancreatic cancer—doctors must examine actual tissue under a microscope. A biopsy is a procedure in which a doctor takes a small sample of tissue from the pancreas. There are several ways to do this. During an endoscopic ultrasound, the doctor can pass a thin needle through the endoscope into the suspicious area and withdraw a few cells or a tiny piece of tissue. This is called an EUS-guided fine needle aspiration (FNA) and is one of the most common biopsy methods for pancreatic cancer.

Another approach is a percutaneous biopsy, in which the doctor uses a CT scan or ultrasound to guide a needle through the skin and into the pancreas to collect tissue. This can be done in a radiology department without general anesthesia, though the patient is usually given sedation to stay comfortable.

The tissue sample is sent to a pathologist—a doctor who studies cells and tissue under a microscope—who looks for cancer cells and determines what type of pancreatic cancer it is. This information is essential because different types of pancreatic cancer may be treated differently. The biopsy results also help doctors understand how aggressive the cancer appears to be.

Blood tests and tumor markers

Blood tests cannot diagnose pancreatic cancer on their own, but they provide supporting information. A test for CA 19-9, a protein called a tumor marker, is often ordered when pancreatic cancer is suspected. People with pancreatic cancer often have elevated CA 19-9 levels in their blood. However, this marker can also be high in people with pancreatitis, other cancers, or benign conditions, so it is not specific enough to diagnose cancer by itself.

Doctors use CA 19-9 mainly in two ways: to support a diagnosis when imaging and biopsy results suggest cancer, and to monitor treatment response after cancer is confirmed. If CA 19-9 drops after surgery or chemotherapy, it suggests the treatment is working. If it rises, it may signal that cancer is returning or spreading.

Other blood tests measure liver function and kidney function, which help doctors understand whether the cancer or inflammation has affected these organs. These tests also provide a baseline before treatment begins.

Staging scans: checking if cancer has spread

Once pancreatic cancer is confirmed, doctors order additional imaging to determine the stage—how far the cancer has spread. This is crucial because stage affects treatment options and prognosis. A CT scan of the chest and abdomen is standard to look for spread to the lungs, liver, and other organs. Some centers also use an MRI (magnetic resonance imaging), which uses magnetic fields instead of radiation and can sometimes show detail that CT misses, particularly in the liver.

A PET scan (positron emission tomography) may be ordered to detect cancer cells in distant parts of the body. The patient receives an injection of a radioactive tracer that collects in areas of high activity, and the scanner detects this radiation. PET scans are particularly useful for finding metastases—cancer that has spread—in bones or distant lymph nodes.

Doctors may also order a staging laparoscopy, a minimally invasive surgical procedure in which a thin camera is inserted through a small cut in the abdomen to directly visualize the pancreas, liver, and abdominal lining. This can reveal small areas of spread that imaging alone might miss and can change treatment planning.

Screening for people at higher risk

Most people are not screened for pancreatic cancer without symptoms because screening is not proven to save lives in the general population. However, people with a strong family history of pancreatic cancer or certain inherited genetic mutations—such as BRCA1, BRCA2, or Lynch syndrome mutations—may be offered screening with imaging and blood tests even if they have no symptoms.

Screening typically involves regular CT scans or endoscopic ultrasounds, sometimes combined with CA 19-9 blood tests. The goal is to catch cancer at an earlier stage when surgery might be more effective. Genetic counseling is usually recommended before screening begins so people understand their actual risk and what screening can and cannot do.

If you have a family history of pancreatic cancer, discuss screening options with your doctor. They can assess your individual risk and recommend whether screening is appropriate for you.

What happens after diagnosis

Once pancreatic cancer is confirmed and staged, your doctor will discuss treatment options. These may include surgery to remove the tumor, chemotherapy, radiation therapy, or a combination of these. The specific plan depends on the stage of the cancer, your overall health, and your preferences.

You will likely meet with a team that may include a surgical oncologist (a surgeon who specializes in cancer), a medical oncologist (who prescribes chemotherapy), and other specialists. This team will review all your test results and recommend a treatment strategy tailored to your situation.

Frequently Asked Questions

Can pancreatic cancer be found by accident on a scan done for another reason?

Yes. Sometimes a CT or MRI scan ordered for an unrelated problem—like abdominal pain or gallstones—reveals an abnormality in the pancreas. When this happens, your doctor will recommend follow-up imaging or biopsy to determine what it is. Not every pancreatic abnormality is cancer, but it must be investigated.

Does a biopsy hurt, and how long does it take?

A biopsy is usually done under sedation, so you are drowsy and do not feel pain during the procedure. You may feel pressure or mild discomfort, but not sharp pain. The procedure itself takes 20 to 45 minutes, depending on the method. You will need someone to drive you home afterward because of the sedation.

What if imaging shows something suspicious but the biopsy is negative?

If imaging is concerning but a biopsy does not show cancer, your doctor may recommend repeat imaging in a few weeks or months to see if the abnormality changes. Sometimes a second biopsy is needed. Benign conditions like cysts or inflammation can look suspicious on imaging but are not cancer.

How long does it take to get a diagnosis after the first scan?

This varies widely. If imaging is clearly abnormal and a biopsy is done right away, a diagnosis may come within one to two weeks. If imaging is uncertain or a biopsy is delayed, it can take several weeks. Your doctor's office can tell you the expected timeline based on your specific situation.

Is there a blood test that can detect pancreatic cancer before symptoms appear?

Not yet for the general population. CA 19-9 and other blood markers are not sensitive or specific enough to screen for pancreatic cancer in people without symptoms. Research is ongoing to develop better early detection blood tests, but they are not yet standard practice outside of clinical trials.